Literature DB >> 22663298

Identification and validation of inhibitor-responsive kinase substrates using a new paradigm to measure kinase-specific protein phosphorylation index.

Xiang Li1, Varsha Rao, Jin Jin, Bin Guan, Kenna L Anderes, Charles J Bieberich.   

Abstract

Regulation of all cellular processes requires dynamic regulation of protein phosphorylation. We have developed an unbiased system to globally quantify the phosphorylation index for substrates of a specific kinase by independently quantifying phosphorylated and total substrate molecules in a reverse in-gel kinase assay. Non-phosphorylated substrate molecules are first quantified in the presence and absence of a specific stimulus. Total substrate molecules are then measured after complete chemical dephosphorylation, and a ratio of phosphorylated to total substrate is derived. To demonstrate the utility of this approach, we profiled and quantified changes in phosphorylation index for Protein Kinase CK2 substrates that respond to a small-molecule inhibitor. A broad range of inhibitor-induced changes in phosphorylation was observed in cultured cells. Differences among substrates in the kinetics of phosphorylation change were also revealed. Comparison of CK2 inhibitor-induced changes in phosphorylation in cultured cells and in mouse peripheral blood lymphocytes in vivo revealed distinct kinetic and depth-of-response profiles. This technology provides a new approach to facilitate functional analyses of kinase-specific phosphorylation events. This strategy can be used to dissect the role of phosphorylation in cellular events, to facilitate kinase inhibitor target validation studies, and to inform in vivo analyses of kinase inhibitor drug efficacy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22663298      PMCID: PMC4133982          DOI: 10.1021/pr3000514

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  56 in total

Review 1.  Protein kinases--the major drug targets of the twenty-first century?

Authors:  Philip Cohen
Journal:  Nat Rev Drug Discov       Date:  2002-04       Impact factor: 84.694

Review 2.  Using small molecules and chemical genetics to interrogate signaling networks.

Authors:  Scott M Carlson; Forest M White
Journal:  ACS Chem Biol       Date:  2010-11-29       Impact factor: 5.100

3.  Large-scale phosphorylation analysis of mouse liver.

Authors:  Judit Villén; Sean A Beausoleil; Scott A Gerber; Steven P Gygi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-22       Impact factor: 11.205

Review 4.  Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2.

Authors:  James S Duncan; David W Litchfield
Journal:  Biochim Biophys Acta       Date:  2007-08-30

Review 5.  Quantitative analysis of cell signaling and drug action via mass spectrometry-based systems level phosphoproteomics.

Authors:  Nathan C Tedford; Amy B Hall; James R Graham; Cheryl E Murphy; Neal F Gordon; Jeffrey A Radding
Journal:  Proteomics       Date:  2009-03       Impact factor: 3.984

6.  Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

Authors:  Jesper V Olsen; Blagoy Blagoev; Florian Gnad; Boris Macek; Chanchal Kumar; Peter Mortensen; Matthias Mann
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

7.  A chemical and phosphoproteomic characterization of dasatinib action in lung cancer.

Authors:  Jiannong Li; Uwe Rix; Bin Fang; Yun Bai; Arthur Edwards; Jacques Colinge; Keiryn L Bennett; Jingchun Gao; Lanxi Song; Steven Eschrich; Giulio Superti-Furga; John Koomen; Eric B Haura
Journal:  Nat Chem Biol       Date:  2010-02-28       Impact factor: 15.040

Review 8.  Protein kinase CK2 in health and disease: Structural bases of protein kinase CK2 inhibition.

Authors:  R Battistutta
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

9.  Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1.

Authors:  Giuseppe Giaccone; Roy S Herbst; Christian Manegold; Giorgio Scagliotti; Rafael Rosell; Vincent Miller; Ronald B Natale; Joan H Schiller; Joachim Von Pawel; Anna Pluzanska; Ulrich Gatzemeier; John Grous; Judith S Ochs; Steven D Averbuch; Michael K Wolf; Pamela Rennie; Abderrahim Fandi; David H Johnson
Journal:  J Clin Oncol       Date:  2004-03-01       Impact factor: 44.544

10.  Regulation of cytosolic prostaglandin E synthase by phosphorylation.

Authors:  Tsuyoshi Kobayashi; Yoshihito Nakatani; Toshihiro Tanioka; Masafumi Tsujimoto; Shigeo Nakajo; Kazuyasu Nakaya; Makoto Murakami; Ichiro Kudo
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

View more
  3 in total

1.  Pharmacologic inhibition of the CK2-mediated phosphorylation of B23/NPM in cancer cells selectively modulates genes related to protein synthesis, energetic metabolism, and ribosomal biogenesis.

Authors:  Yasser Perera; Seidy Pedroso; Orlando Borras-Hidalgo; Dania M Vázquez; Jamilet Miranda; Adelaida Villareal; Viviana Falcón; Luis D Cruz; Hernán G Farinas; Silvio E Perea
Journal:  Mol Cell Biochem       Date:  2015-03-25       Impact factor: 3.396

2.  Quantifying Kinase-Specific Phosphorylation Stoichiometry Using Stable Isotope Labeling In a Reverse In-Gel Kinase Assay.

Authors:  Xiang Li; Jonathan T Cox; Weiliang Huang; Maureen Kane; Keqi Tang; Charles J Bieberich
Journal:  Anal Chem       Date:  2016-11-18       Impact factor: 6.986

3.  Protein kinase A regulates MYC protein through transcriptional and post-translational mechanisms in a catalytic subunit isoform-specific manner.

Authors:  Achuth Padmanabhan; Xiang Li; Charles J Bieberich
Journal:  J Biol Chem       Date:  2013-03-15       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.